
Is Your CE submission ready for a Notified Body?
Assess Your EU MDR & IVDR Compliance Gaps in 2 Minutes
How is a medical device classified under EU MDR and IVDR?
How is a medical device classified under EU MDR and IVDR?
Medical device classification under EU MDR uses 22 rules in Annex VIII and sorts devices into classes I, IIa, IIb and III. EU IVDR uses 7 rules in its own Annex VIII and classes A to D. The class follows from the intended purpose and decides the conformity assessment route, including whether a Notified Body is involved.
Record which rule you applied and why, and keep that rationale in the technical documentation, because a Notified Body will ask for it. The intended purpose should read the same in your labeling, instructions for use and clinical documents. The MDR rules are set out in MDR Annex VIII, and the IVDR rules in IVDR Annex VIII.
Is ISO 13485 enough for an MDR or IVDR quality management system?
ISO 13485:2016 is the usual basis for a quality management system (QMS), but certification alone does not show regulatory compliance. EU MDR and EU IVDR each require a QMS proportionate to the risk class and type of device, with procedures that cover the processes the regulation names, from risk management to post-market surveillance.
Check that your procedures cover regulatory compliance, design and development, risk management, supplier control, clinical or performance evaluation and post-market surveillance, and that your records show them in use. For most devices above class I, the Notified Body assesses the system as well as the documentation. The requirement sits in MDR Article 10(9) and IVDR Article 10(8), and the standard is ISO 13485:2016.
What must technical documentation contain under MDR and IVDR?
Technical documentation under EU MDR and EU IVDR follows Annexes II and III of each regulation. It covers the device description and specification, information supplied with the device, design and manufacturing information, the General Safety and Performance Requirements (GSPR) checklist, benefit-risk analysis, risk management, verification and validation, and post-market surveillance documentation.
The GSPR checklist in Annex I is the map of the file. For each requirement it states whether the requirement applies, how you meet it and where the evidence sits, and a requirement marked not applicable needs a justification. Risk management usually follows ISO 14971:2019, and its controls should appear in your design inputs. Present the file in a clear, organized and searchable form, and keep the versions you submit aligned with your QMS. See MDR Annexes II and III for the MDR text.
What does a clinical or performance evaluation need to show?
A clinical evaluation under EU MDR (Article 61, Annex XIV) or a performance evaluation under EU IVDR (Article 56, Annex XIII) must show that a device is safe and performs as intended, with data that supports every claim. Both are continuous processes that are updated with post-market data throughout the life of the device.
The plan, the evidence and the report should link to each other and to your risk management file. For a closer check on the MDR side, take the Clinical Evaluation Readiness Check. The legal basis is MDR Article 61 and Annex XIV and IVDR Article 56 and Annex XIII.
When do I need a Notified Body for CE marking?
A Notified Body is an independent conformity assessment body designated by an EU Member State to assess devices under EU MDR or EU IVDR. Manufacturers need one for most devices above the lowest risk class, and the exact requirement depends on the device class and the conformity assessment route chosen.
MDR class I devices that are non-sterile, have no measuring function and are not reusable surgical instruments do not need one, and neither do class A non-sterile IVDs under IVDR. The routes are described in Annexes IX to XI of both regulations. Start the conversation before the file is final, because the application and review run on the Notified Body's schedule. Our dossier submission support covers the preparation.
What does post-market surveillance require?
Post-market surveillance (PMS) is the system a manufacturer runs to collect and analyze data on a device in the field. EU MDR requires a PMS plan, a PMS report or a periodic safety update report (PSUR) depending on class, and post-market clinical follow-up (PMCF). EU IVDR requires matching PMS documentation and post-market performance follow-up (PMPF).
The PMS plan is part of the technical documentation (Annex III), so it has to exist when you submit, and the Notified Body will look for evidence that it is running and producing data. The MDR requirements are in MDR Articles 83 to 86. The IVDR equivalent is in IVDR Chapter VII.
What are EUDAMED registration and UDI, and are they mandatory?
EUDAMED is the European database on medical devices, and the Unique Device Identification (UDI) system identifies each device through a Basic UDI-DI and a UDI-DI. Since 28 May 2026, manufacturers must use four EUDAMED modules under EU MDR and EU IVDR: actor registration, UDI and device registration, Notified Bodies and certificates, and market surveillance.
The Basic UDI-DI links your certificates, declarations of conformity and EUDAMED entries, so settle its structure early. Four of the six EUDAMED modules are mandatory so far, and the others follow later. The Commission's notice is here: mandatory use of the first four EUDAMED modules.
Get a tailored CE submission gap review
Qserve's regulatory consultants can walk through your specific gaps with you in a free 30-minute call, with no agenda and no obligation.
Frequently Asked Questions
Couldn't find your question?
Does a high score mean my submission will be accepted?
No. The quiz is a short self-assessment that shows where to look first. It does not replace a gap assessment of your documents, and it is not an opinion of a Notified Body.
Where should I start if the quiz shows gaps in several areas?
Start with classification, because the class decides the conformity route and what every other area must contain. Then work through the items marked urgent in your result. Clinical or performance evidence and Notified Body engagement tend to take the longest, so they need early planning.
What is the difference between a PMS report and a PSUR?
Under EU MDR, manufacturers of class I devices prepare a PMS report, and manufacturers of class IIa, IIb and III devices prepare a PSUR. A PSUR is updated at least every two years for class IIa and at least annually for classes IIb and III. The rules are in MDR Articles 85 and 86.
What is the difference between a Basic UDI-DI and a UDI-DI?
The Basic UDI-DI is the main access key to a device's records in EUDAMED, and it appears on certificates, declarations of conformity and technical documentation. It groups devices that share an intended purpose, a risk class and essential design and manufacturing characteristics. A UDI-DI identifies one specific version or packaging level and appears on the label. See MDR Annex VI, Part C.
Latest blogs
.png)
Avoid enrollment delays and query backlogs. What to check before selecting a site for your medical device clinical investigation, from study team capacity to pharmacy agreements.
.png)
Know if your device needs a clinical investigation under MDR, and how ISO 14155:2026 shapes the study. Learn the exemptions, pitfalls and next steps.
.png)
Missing the 28 November EUDAMED deadline puts your devices at risk of non-compliance. Learn what’s at stake and how to get your data submitted in time.